Publications Welcome to Enlighten Publications. View the latest additions to the repository, browse by category or search for specific publications here.

Incorporating a polyethyleneglycol linker to enhance the hydrophilicity of mitochondria‐targeted triphenylphosphonium constructs

Uno, Shinpei, Harkiss, Alexander H., Chowdhury, Roy, Caldwell, Stuart T. ORCID logoORCID: https://orcid.org/0000-0003-1604-3462, Prime, Tracy A., James, Andrew M., Gallagher, Brendan, Prudent, Julien, Hartley, Richard C. ORCID logoORCID: https://orcid.org/0000-0003-1033-5405 and Murphy, Michael P. (2023) Incorporating a polyethyleneglycol linker to enhance the hydrophilicity of mitochondria‐targeted triphenylphosphonium constructs. ChemBioChem, 24(11), e202200774. (doi: 10.1002/cbic.202200774) (PMID:36917207) (PMCID:PMC10946768)

[thumbnail of 295018.pdf] Text
295018.pdf - Published Version
Available under License Creative Commons Attribution.

3MB

Abstract

The targeting of bioactive molecules and probes to mitochondria can be achieved by coupling to the lipophilic triphenyl phosphonium (TPP) cation, which accumulates several hundred-fold within mitochondria in response to the mitochondrial membrane potential (Dym). Typically, a simple alkane links the TPP to its “cargo”, increasing overall hydrophobicity. As it would be beneficial to enhance the water solubility of mitochondria-targeted compounds we explored the effects of replacing the alkyl linker with a polyethylene glycol (PEG). We found that the use of PEG led to compounds that were readily taken up by isolated mitochondria and by mitochondria inside cells. Within mitochondria the PEG linker greatly decreased adsorption of the TPP constructs to the matrix-facing face of the mitochondrial inner membrane. These findings will allow the distribution of mitochondria-targeted TPP compounds within mitochondria to be fine-tuned.

Item Type:Articles
Additional Information:This work was supported by the Medical Research Council UK (MC_UU_00028/4) and by Wellcome Trust Investigator awards to MPM (220257/Z/20/Z) and RCH (220257/B/20/Z). JP was supported by the Medical Research Council UK (MC_UU_00028/5). BG's PhD studentship was supported by the Engineering and Physical Sciences Research Council (EP/R513222/1). SU was supported by an Overseas fellowship from Japan Society for the Promotion of Science (202260220).
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Caldwell, Dr Stuart and Hartley, Professor Richard and Harkiss, Dr Alexander
Authors: Uno, S., Harkiss, A. H., Chowdhury, R., Caldwell, S. T., Prime, T. A., James, A. M., Gallagher, B., Prudent, J., Hartley, R. C., and Murphy, M. P.
College/School:College of Science and Engineering > School of Chemistry
Journal Name:ChemBioChem
Publisher:Wiley
ISSN:1439-4227
ISSN (Online):1439-7633
Published Online:14 March 2023
Copyright Holders:Copyright © 2023 The Authors
First Published:First published in ChemBioChem 24(11): e202200774
Publisher Policy:Reproduced under a Creative Commons License
Data DOI:10.5525/gla.researchdata.1385

University Staff: Request a correction | Enlighten Editors: Update this record

Project Code
Award No
Project Name
Principal Investigator
Funder's Name
Funder Ref
Lead Dept
Exploring mitochondrial metabolism in health and disease using targeted biological chemistry
Richard Hartley
220257/B/20/Z
Chemistry
DTP 2018-19 University of Glasgow
Mary Beth Kneafsey
EP/R513222/1
MVLS - Graduate School

Downloads per month over past year

View more statistics